手足症候群
(Chemotherapy-induced acral erythema から転送)
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2023/07/15 15:20 UTC 版)
手足症候群（てあししょうこうぐん、英: hand-foot syndrome、HFS）または手掌足底発赤知覚不全症候群（しゅしょうそくていほっせきちかくふぜんしょうこうぐん、英: palmar-plantar erythrodysesthesia、PPE）または 肢端紅斑異感覚症候群（したんこうはんいかんかくしょうこうぐん、英: acral erythrodysesthesia syndrome、AE）またはBurgdorf反応（バーグドルフはんのう）とは、抗悪性腫瘍剤の副作用としてみられる皮膚症状。
- ^ a b c Baack BR, Burgdorf WH (1991). “Chemotherapy-induced acral erythema.”. J Am Acad Dermatol 24 (3): 457-61. doi:10.1016/0190-9622(91)70073-B. PMID 2061446.
- ^ Demirçay Z, Gürbüz O, Alpdoğan TB, Yücelten D, Alpdoğan O, Kurtkaya O et al. (1997). “Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases.”. Int J Dermatol 36 (8): 593-8. doi:10.1046/j.1365-4362.1997.00040.x. PMID 9329890.
- ^ a b Narin Apisarnthanarax, Madeleine M. Duvic (2003-07). Cancer Medicine 6:Review : A companion to Holland-Frei. B C Decker Inc. ISBN 978-1550092134
- ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.:132
- ^ Palmar-plantar rash with cytarabine therapy. Rosenbeck L, Kiel PJ. N Engl J Med. 2011 Jan 20;364(3):e5.
- ^ Lacouture ME, Reilly LM, Gerami P, Guitart J (2008). “Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib”. J. Ann Oncol 19 (11): 1955–61. doi:10.1093/annonc/mdn389.
- ^ Lademann, Juergen; Martschick, Anja; Kluschke, Franziska; Richter, Heike; Fluhr, Joachim W.; Patzelt, Alexa; Jung, Sora; Chekerov, Radoslav et al. (2014). “Efficient prevention strategy against the development of a palmar-plantar erythrodysesthesia during chemotherapy”. Skin Pharmacology and Physiology 27 (2): 66–70. doi:10.1159/000351801. ISSN 1660-5535. PMID 23969763.
- ^ Crider MK, Jansen J, Norins AL, McHale MS (1986). “Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation.”. Arch Dermatol 122 (9): 1023-7. doi:10.1001/archderm.1986.01660210073021. PMID 3527075.
- ^ Zimmerman GC, Keeling JH, Burris HA, Cook G, Irvin R, Kuhn J et al. (1995). “Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent.”. Arch Dermatol 131 (2): 202-6. doi:10.1001/archderm.131.2.202. PMID 7857119.
- ^ von Moos, Roger; Thuerlimann, Beat J. K.; Aapro, Matti; Rayson, Daniel; Harrold, Karen; Sehouli, Jalid; Scotte, Florian; Lorusso, Domenica et al. (April 2008). “Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts”. European Journal of Cancer (Oxford, England: 1990) 44 (6): 781–790. doi:10.1016/j.ejca.2008.01.028. ISSN 0959-8049. PMID 18331788.
- ^ Cutaneous complications of conventional chemotherapy agents. Payne AS, Savarese DMF. In: UpToDate [Textbook of Medicine]. Massachusetts Medical Society, and Wolters Kluwer publishers. 2010.
- ^ “Management of hand-foot syndrome induced by capecitabine”. J Oncol Pharm Pract 12 (3): 131–41. (Sep 2006). doi:10.1177/1078155206069242.
- ^ Vukelja SJ, Baker WJ, Burris HA 3rd, Keeling JH, Von Hoff D. "Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere. J Natl Cancer Inst. 1993 Sep 1;85(17):1432-3.
- ^ Juergen Barth (2004年3月). “Letter to the editor - 5-FU induced palmar-plantar erythrodyesthesia – a hospital pharmacy developed "antidot"”. Journal of Oncology Pharmacy Practice 10 (57)
- ^ Yucel, Idris; Guzin, Gonullu (2008-04). “Topical henna for capecitabine induced hand-foot syndrome”. Investigational New Drugs 26 (2): 189–192. doi:10.1007/s10637-007-9082-3. ISSN 0167-6997. PMID 17885735.
- ^ Hartinger, J.; Veselý, P.; Matoušková, E.; Argalacsová, S.; Petruželka, L.; Netíková, I. (2012). “Local treatment of hand-foot syndrome with uridine/thymidine: in vitro appraisal on a human keratinocyte cell line HaCaT”. TheScientificWorldJournal 2012: 421325. doi:10.1100/2012/421325. ISSN 1537-744X. PMC 3417181. PMID 22919318.
- ^ Hand-Foot Syndrome in cancer patients: concepts, assessment and management of symptoms. 2013.
- ^ Ilyas, Saher; Wasif, Komal; Saif, Muhammad Wasif (2014-09). “Topical henna ameliorated capecitabine-induced hand-foot syndrome”. Cutaneous and Ocular Toxicology 33 (3): 253–255. doi:10.3109/15569527.2013.832280. ISSN 1556-9535. PMID 24021017.
- ^ Irena Netikova; Agnes Petska; Juergen Barth (2009). “Recent clinical studies with uridine cream”. EJOP. Oncology Pharmacy Practice 3 (2): 22–23.
- ^ Zuehlke RL (1974). “Erythematous eruption of the palms and soles associated with mitotane therapy”. Dermatologica 148 (2): 90–2. doi:10.1159/000251603. PMID 4276191.
[続きの解説]
「手足症候群」の続きの解説一覧
- 1 手足症候群とは
- 2 手足症候群の概要
- 3 治療
- Chemotherapy-induced acral erythemaのページへのリンク
